Baseline Tumor Burden Assessed With AI‐Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR‐T in Aggressive B‐Cell Lymphoma
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Eugenio Galli, Andrea Guarneri, Federica Sorà, Marcello Viscovo, Ilaria Pansini, Elena Maiolo, Eleonora Alma, Salvatore Annunziata, Simona Sica, Lucia Leccisotti, Stefan Hohaus |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Predicting therapy‐related myeloid neoplasms after CAR‐T with the Clonal Haematopoiesis Risk Score (CHRS)
por: Eugenio Galli, et al.
Publicado: (2024)
por: Eugenio Galli, et al.
Publicado: (2024)
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR‐T
por: Eugenio Galli, et al.
Publicado: (2025)
por: Eugenio Galli, et al.
Publicado: (2025)
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti‐CD19 Chimeric Antigen Receptor (CAR) T‐Cell Therapy
por: Anna Modoni, et al.
Publicado: (2025)
por: Anna Modoni, et al.
Publicado: (2025)
Coagulopathy in CAR‐T: Critical concern or mere blip?
por: Eugenio Galli, et al.
Publicado: (2024)
por: Eugenio Galli, et al.
Publicado: (2024)
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation
por: Marcello Viscovo, et al.
Publicado: (2024)
por: Marcello Viscovo, et al.
Publicado: (2024)
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B‐Cell Lymphoma
por: Swetha Kambhampati Thiruvengadam, et al.
Publicado: (2024)
por: Swetha Kambhampati Thiruvengadam, et al.
Publicado: (2024)
Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2‐[ 18 F]FDG PET/CT in Advanced Mantle Cell Lymphoma
por: Domenico Albano, et al.
Publicado: (2024)
por: Domenico Albano, et al.
Publicado: (2024)
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir‐exposed CMV‐free population receiving PTCy
por: Eugenio Galli, et al.
Publicado: (2024)
por: Eugenio Galli, et al.
Publicado: (2024)
Unselected donor‐derived hematopoietic stem cells boost for Chimeric Antigen Receptor T‐cell associated hematotoxicity
por: Eugenio Galli, et al.
Publicado: (2024)
por: Eugenio Galli, et al.
Publicado: (2024)
Venous Thromboembolism in Aggressive B‐Cell Lymphoma Patients Treated with CD19 CAR‐T Therapy: Single‐Institution Study
por: Neha Venkatesh, et al.
Publicado: (2026)
por: Neha Venkatesh, et al.
Publicado: (2026)
Cross‐Sectional Analysis of Metabolic Tumor Burden Detected by F‐18 FDG PET/CT and Circulating Tumor DNA in Advanced Breast Cancer
por: Recep Halit Tokac, et al.
Publicado: (2025)
por: Recep Halit Tokac, et al.
Publicado: (2025)
Tumor Growth in Overdrive: Detailing an Aggressive Course of Hepatocellular Carcinoma
por: Simardeep Singh, et al.
Publicado: (2024)
por: Simardeep Singh, et al.
Publicado: (2024)
Aggressive Glioblastoma Cells Enhance the Migratory Persistence and Velocity of Less Aggressive Cells to Promote Tumor Dissemination
por: Fatima‐ezzahra Ait Mohand, et al.
Publicado: (2026)
por: Fatima‐ezzahra Ait Mohand, et al.
Publicado: (2026)
Nanomaterials Boost CAR‐T Therapy for Solid Tumors
por: Jun Long, et al.
Publicado: (2024)
por: Jun Long, et al.
Publicado: (2024)
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry
por: Silvia Bellesi, et al.
Publicado: (2024)
por: Silvia Bellesi, et al.
Publicado: (2024)
Aggressive Myeloid Sarcoma Mimicking Burkitt's Lymphoma
por: Eman Hassan, et al.
Publicado: (2025)
por: Eman Hassan, et al.
Publicado: (2025)
TACE: Tumor-Aware Counterfactual Explanations
por: Rossi, Eleonora Beatrice, et al.
Publicado: (2024)
por: Rossi, Eleonora Beatrice, et al.
Publicado: (2024)
CAR T‐Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real‐World Experiences From a Single Center on the Use of Radiotherapy
por: J.T. Jutzi, et al.
Publicado: (2025)
por: J.T. Jutzi, et al.
Publicado: (2025)
Metabolic Heterogeneity Confers Differences in the Tumor Microenvironment of Aggressive Types of Melanomas
por: Juliana de Souza do Nascimento, et al.
Publicado: (2025)
por: Juliana de Souza do Nascimento, et al.
Publicado: (2025)
Educação Inclusiva: cultura e cotidiano escolar. GLAT, Rosana. (org.) educação Inclusiva:cultura e cotidiano escolar. Rio de Janeiro: 7Letras, 2007.
por: Flávia Pansini
Publicado: (2011)
por: Flávia Pansini
Publicado: (2011)
O ingresso de crianças de 6 anos no ensino fundamental: uma pesquisa em Rondônia
por: Flávia Pansini
Publicado: (2011)
por: Flávia Pansini
Publicado: (2011)
Nanotechnology‐Assisted CAR‐T‐Cell Therapy for Tumor Treatment
por: Yixin Wang, et al.
Publicado: (2024)
por: Yixin Wang, et al.
Publicado: (2024)
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
por: Danqing Zhu, et al.
Publicado: (2025)
por: Danqing Zhu, et al.
Publicado: (2025)
Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients
por: A. Zduniak, et al.
Publicado: (2024)
por: A. Zduniak, et al.
Publicado: (2024)
Routine Monitoring of CAR‐T‐Cells Expansion and Persistence in Patients With Aggressive Large B‐Cell Lymphoma by Flow Cytometry: A Single‐Center Experience
por: Alexandra Zduniak, et al.
Publicado: (2025)
por: Alexandra Zduniak, et al.
Publicado: (2025)
Construction of Lymphoma Organoids and Applications in Tumor Microenvironment Research
por: Miao Zhu, et al.
Publicado: (2025)
por: Miao Zhu, et al.
Publicado: (2025)
Diagnosis and Management of Aggressive/Refractory Growth Hormone‐Secreting Pituitary Neuroendocrine Tumors
por: Xiaojuan Zhang, et al.
Publicado: (2024)
por: Xiaojuan Zhang, et al.
Publicado: (2024)
FTIR Markers of Prostate Cancer Tissue and Their Correlation With Medical Parameters of Tumor Aggressiveness
por: Przemysław Mitura, et al.
Publicado: (2025)
por: Przemysław Mitura, et al.
Publicado: (2025)
Tumor‐Associated Lactic Acidosis and Early Death in Patients With Lymphoma
por: Bahaa Atamna, et al.
Publicado: (2025)
por: Bahaa Atamna, et al.
Publicado: (2025)
Understanding the Burden of Care for Children With Pediatric Solid Tumors
por: Julie M. Thamby, et al.
Publicado: (2026)
por: Julie M. Thamby, et al.
Publicado: (2026)
Tumor‐Associated Fusobacterium nucleatum and Aggressive Architectural Features in Stage II Colorectal Cancer
por: Mariana Bisarro dos Reis, et al.
Publicado: (2026)
por: Mariana Bisarro dos Reis, et al.
Publicado: (2026)
The Significance of Circulating Basophils as Predictors of Tumor Aggressiveness in Clear‐Cell Renal Cell Carcinoma
por: Burak Arslan, et al.
Publicado: (2025)
por: Burak Arslan, et al.
Publicado: (2025)
Synthetic Biology and Biomaterials Strategies to Deceive the Tumor Microenvironment in CAR‐T Immunotherapy
por: Grazia Marsico, et al.
Publicado: (2025)
por: Grazia Marsico, et al.
Publicado: (2025)
CAR‐NK, a Splendid Strategy for Cancer, Especially for Gynecologic Tumor
por: Yisen Cao, et al.
Publicado: (2025)
por: Yisen Cao, et al.
Publicado: (2025)
Targeting the Dynamics Between TAMs and CAR‐T Cells in Solid Tumor Therapies
por: Xiang Zhang, et al.
Publicado: (2025)
por: Xiang Zhang, et al.
Publicado: (2025)
In Vivo Monitoring and Magnetically‐Enhanced Delivery of CAR T‐Cells to Solid Tumor
por: Huan Chen, et al.
Publicado: (2024)
por: Huan Chen, et al.
Publicado: (2024)
Técnica con indocianina verde (ICG) como predictor de la falla de sutura: inicio de la experiencia en nuestro medio
por: Carolina Guarneri
Publicado: (2016)
por: Carolina Guarneri
Publicado: (2016)
Aggressive Desmoplastic Small Round Cell Tumor in an Adult: A Case Report and Literature Review
por: Seyed Amir Aledavood, et al.
Publicado: (2026)
por: Seyed Amir Aledavood, et al.
Publicado: (2026)
Semiquantitative PET Parameters Refine Prognosis in CAR T-Treated Lymphoma after 1 and 3 Months: A Prospective Single-Center Study
por: Farolfi, Andrea, et al.
Publicado: (2025)
por: Farolfi, Andrea, et al.
Publicado: (2025)
ODC ‐Driven Polyamines Synthesis Sustains the Self‐Renewal of Glioblastoma Stem Cells and Drives Tumor Aggressiveness
por: Xue‐Chen Wei, et al.
Publicado: (2025)
por: Xue‐Chen Wei, et al.
Publicado: (2025)
Ejemplares similares
-
Predicting therapy‐related myeloid neoplasms after CAR‐T with the Clonal Haematopoiesis Risk Score (CHRS)
por: Eugenio Galli, et al.
Publicado: (2024) -
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR‐T
por: Eugenio Galli, et al.
Publicado: (2025) -
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti‐CD19 Chimeric Antigen Receptor (CAR) T‐Cell Therapy
por: Anna Modoni, et al.
Publicado: (2025) -
Coagulopathy in CAR‐T: Critical concern or mere blip?
por: Eugenio Galli, et al.
Publicado: (2024) -
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation
por: Marcello Viscovo, et al.
Publicado: (2024)